आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
arzotilol (dorzolamid + timolol actavis) augndropar, lausn 20 mg/ml +5 mg/ml
teva b.v.* - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml +5 mg/ml
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
cosopt sine augndropar, lausn 20 mg/ml+5 mg/ml
santen oy* - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml+5 mg/ml
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
duokopt (joz) augndropar, lausn 20 mg/ml + 5 mg/ml
laboratoires thea s.a.s. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml + 5 mg/ml
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
timosan depot í stakskammtaíláti augnhlaup í stakskammtaíláti 1 mg/g
santen oy* - timololum maleat - augnhlaup í stakskammtaíláti - 1 mg/g
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
dorzolamide/timolol alvogen augndropar, lausn 20mg/ml+5 mg/ml
alvogen ehf. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20mg/ml+5 mg/ml
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
fotil forte augndropar, lausn í stakskammtaíláti 5 mg + 40 mg/ml
santen oy* - pilocarpini chloridum nfn; timololum maleat - augndropar, lausn í stakskammtaíláti - 5 mg + 40 mg/ml
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
xalcom augndropar, lausn
upjohn eesv - latanoprostum inn; timololum maleat - augndropar, lausn
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
fixopost (monoprostduo) augndropar, lausn í stakskammtaíláti 50 míkróg/ml + 5 mg/ml
laboratoires thea* - latanoprostum inn; timololum maleat - augndropar, lausn í stakskammtaíláti - 50 míkróg/ml + 5 mg/ml
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
travoprost/timolol medical valley augndropar, lausn 40 míkróg/ml + 5 mg/ml
medical valley invest ab - travoprostinum inn; timololum maleat - augndropar, lausn - 40 míkróg/ml + 5 mg/ml
यूरोपीय संघ -
आइसलैंडी -
EMA (European Medicines Agency)
ganfort
abbvie deutschland gmbh & co. kg - bimatoprost, notkunar í augu. - glaucoma, open-angle; ocular hypertension - augnlækningar - minnkun á augnþrýstingi (iop) hjá sjúklingum með gláku í augnlokum eða augnháþrýstingi sem eru ekki nægilega svör við staðbundnum beta-blokkum eða prostaglandín hliðstæðum.